Showing results (121-130 of 3,361) with videos related to
Sort By:
Pageof 337
Journal of Clinical Microbiology|July 1, 1993
Levofloxacin disk potency and tentative interpretive criteria for susceptibility testsM A Pfaller, A L Barry, P C FuchsJournal of Clinical Microbiology|July 1, 1993
Ramoplanin susceptibility testing criteriaA L Barry, M A Pfaller, P C FuchsJournal of Clinical Microbiology|January 1, 1997
Interpretive criteria and quality control parameters for testing of susceptibilities of Haemophilus influenzae and Streptococcus pneumoniae to trimethoprim and trimethoprim-sulfamethoxazole. The Antimicrobial Susceptibility Testing OC GroupP C Fuchs, A L Barry, S D BrownThe Journal of Antimicrobial Chemotherapy|January 1, 1993
RO 23-9424, a new cephalosporin 3'-quinolone: in-vitro antimicrobial activity and tentative disc diffusion interpretive criteriaM A Pfaller, A L Barry, P C FuchsDiagnostic Microbiology and Infectious Disease|April 1, 1996
Survey of antimicrobial activity of four commonly used third generation cephalosporins tested against recent bacterial isolates from ten American medical centers, and assessment of disk diffusion test performance. AST Surveillance GroupP C Fuchs, A L Barry, S D BrownAntimicrobial Agents and Chemotherapy|January 1, 1993
Susceptibilities of beta-lactamase-producing and -nonproducing ampicillin-resistant strains of Haemophilus influenzae to ceftibuten, cefaclor, cefuroxime, cefixime, cefotaxime, and amoxicillin-clavulanic acidA L Barry, P C Fuchs, M A PfallerThe Journal of Antimicrobial Chemotherapy|December 16, 1998
Susceptibility to RPR 106,972, quinupristin/dalfopristin and erythromycin among recent clinical isolates of enterococci, staphylococci and streptococci from North American medical centresA L Barry, P C Fuchs, S D BrownThe Journal of Antimicrobial Chemotherapy|May 1, 1997
Provisional interpretive criteria for quinupristin/dalfopristin susceptibility testsA L Barry, P C Fuchs, S D BrownAntimicrobial Agents and Chemotherapy|April 29, 1998
Antipneumococcal activities of a ketolide (HMR 3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin), and a lincosamide (clindamycin)A L Barry, P C Fuchs, S D BrownThe Journal of Antimicrobial Chemotherapy|June 25, 1999
Fosfomycin tromethamine susceptibility of outpatient urine isolates of Escherichia coli and Enterococcus faecalis from ten North American medical centres by three methodsP C Fuchs, A L Barry, S D BrownPageof 337